3D Spherical Alpha-Helix Polypeptide for Gene Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Traditional gene delivery vectors, such as cationic polypeptides, suffer from cytotoxicity due to excessive membrane disruption and inefficient gene transfection, especially at high doses or over prolonged cell contact.
Innovation Solution
A three-dimensional spherical α-helical polypeptide is developed through ring-opening polymerization of N-carboxylic anhydride monomers, with small molecule modification to enhance gene delivery efficiency. The polypeptide's three-dimensional structure and modified side chains improve complexation with siRNA and membrane penetration, reducing cytotoxicity and enhancing gene transfection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional cationic polypeptides are used at high doses or for prolonged cell contact, then gene delivery efficiency is improved, but cytotoxicity increases due to excessive membrane disruption
Solution Approach 1:
The patent divides the polypeptide into modular units with specific functional segments: a cationic core for membrane interaction, an α-helical region for structural stability, and terminal groups for controlled degradation. This segmentation allows the polypeptide to deliver genes efficiently while limiting membrane disruption to necessary levels, reducing cytotoxicity.
Solution Approach 2:
The patent modifies key parameters of the polypeptide structure including charge density, hydrophobicity, and molecular weight to optimize the balance between gene delivery efficiency and cytotoxicity. By controlling these parameters, the polypeptide achieves effective transfection at lower doses without excessive membrane disruption.
2Strength
If traditional cationic polypeptides are used, then membrane penetration ability is improved, but gene transfection efficiency decreases due to excessive membrane disruption
Solution Approach 1:
The patent introduces dynamic conformational changes in the polypeptide structure, where the α-helical region can transition between different states to facilitate controlled membrane penetration. This dynamic behavior allows the polypeptide to penetrate membranes effectively while maintaining structural integrity for subsequent gene delivery, improving transfection efficiency.
3Productivity
If polypeptide dosage is increased to improve gene delivery, then transfection efficiency is improved, but cytotoxicity increases
Solution Approach 1:
The patent designs the polypeptide with self-regulating properties where the cationic groups automatically interact with negative charges on cell membranes and nucleic acids, and the α-helical structure self-assembles to form stable complexes. This self-service mechanism eliminates the need for high doses, achieving effective transfection at low concentrations without cytotoxicity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The three-dimensional spherical α-helical polypeptide achieves high gene delivery efficiency with low cytotoxicity, effectively transfecting genes into cells and escaping intron/lysosome compartments, making it suitable for photothermal-gene combined therapy of breast cancer.
Implementation Method 1
If positively charged groups such as guanidinium group and aromatic group are introduced into the side chain of polypeptide, it can improve the complexation ability of polypeptide with siRNA through hydrophobic interaction, and thus improve the gene silencing efficiency of polypeptide.
Implementation Method 2
these polypeptides mainly 'punch holes' in the biofilm and penetrate cell membrane through the rigid secondary structure of the α-helix.
Implementation Method 3
α-helical cationic polypeptide can also 'punch' on the lysosomal/intron membrane, so it can deliver nucleic acid molecules into the cell and escape from the intron/lysosome with high efficiency and low energy consumption to achieve efficient gene transfection.
Data Source
AI summary
A three-dimensional star-shaped α-helix polypeptide having a high-efficiency gene delivery capability, and a preparation method and an application thereof. A dendrimer is used as an initiator and dichloromethane is used as a reaction solvent to initiate high-speed ring-opening polymerization of different types of N-carboxylic anhydride monomers, and groups having different electrical properties are introduced at the ends via click chemistry reactions. The abundant amino groups on the surface of the dendrimer provide enough polymerization sites to enable the polypeptide to form a three-dimensional spherical topological structure, and the topological structure provides an opportunity for initial acceleration of the ring-opening polymerization reaction. The higher positive charge density caused by polypeptide side chain modified guanidine/amino groups etc. achieves a high-efficiency gene loading capability by the electrostatic effect between positive and negative charges, and the α-helix rigid structure on the secondary structure thus enables the polypeptide to have stronger membrane penetration capability.